Skip to main
CBLL

Ceribell Inc (CBLL) Stock Forecast & Price Target

Ceribell Inc (CBLL) Analyst Ratings

Based on 6 analyst ratings
Strong Buy
Strong Buy 83%
Buy 17%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

CeriBell Inc. is poised for substantial growth, projecting revenues of $87M-$89M in 2025, reflecting a year-over-year increase of 33%-36%, driven by strategic investments in its salesforce and expanded market presence. The company is focusing on increasing account penetration, particularly in VA hospitals and new demographics, which positions it well for continued commercial traction and operational leverage. With gross margins nearing optimization in the mid-80% range and a dual-stream revenue model, CeriBell is well-equipped to achieve cash-flow breakeven while pursuing long-term profitability through innovative pipeline initiatives.

Bears say

CeriBell Inc. is currently not generating free cash flow and reported a substantial net loss of $40 million in the latest fiscal year, highlighting the company's financial instability. The company faces additional margin pressures due to tariffs and legal expenses, which could further decrease its gross margins amid potential increases in import tariffs or supply chain disruptions. Furthermore, CeriBell operates with a low market capitalization and a history of operating losses, compounded by a relatively low penetration rate of 25-30% within its existing accounts, indicating challenges in sustaining growth in a competitive environment.

Ceribell Inc (CBLL) has been analyzed by 6 analysts, with a consensus rating of Strong Buy. 83% of analysts recommend a Strong Buy, 17% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ceribell Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ceribell Inc (CBLL) Forecast

Analysts have given Ceribell Inc (CBLL) a Strong Buy based on their latest research and market trends.

According to 6 analysts, Ceribell Inc (CBLL) has a Strong Buy consensus rating as of Jan 2, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $24.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $24.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ceribell Inc (CBLL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.